4.4 Article

TGF-β induced by interleukin-34-stimulated microglia regulates microglial proliferation and attenuates oligomeric amyloid β neurotoxicity

Journal

NEUROSCIENCE LETTERS
Volume 529, Issue 1, Pages 86-91

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.neulet.2012.08.071

Keywords

TGF-beta; IL-34; Microglia; Neuroprotection; Oligomeric amyloid beta

Categories

Funding

  1. China Scholarship Council (CSC)
  2. Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)
  3. MEXT
  4. Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO)
  5. Grants-in-Aid for Scientific Research [24659430] Funding Source: KAKEN

Ask authors/readers for more resources

Microglia play critical roles in the pathogenesis of Alzheimer's disease (AD). We have previously shown that interleukin-34 (IL-34) enhances microglial proliferation and induces microglial neuroprotective properties against oligomeric amyloid beta (oA beta) toxicity by producing insulin degrading enzyme, an A beta degrading enzyme, and anti-oxidant enzyme heme oxygenase-1. In this study, we found that IL-34 dose-dependently induces TGF-beta in microglia, and that TGF-beta attenuates oA beta neurotoxicity in neuron microglial co-cultures. The TGF-beta 1 receptor kinase inhibitor SD208 enhances microglial proliferation by IL-34 and suppresses the neuroprotective effect of IL-34-treated microglia. These findings suggest that TGF-beta produced by IL-34-treated microglia is a negative regulator of microglial proliferation and enhances the neuroprotective property of microglia. (C) 2012 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available